FENTON, Mo. (KMOX) –  As a post-tsumani nuclear crisis looms in Japan, concerns are stretching half way around the globe to the St. Louis area.

Quoting a Wall Street Journal article, the St. Louis Business Journal reports Wednesday that fear of radiation exposure from those damaged nuclear plants has created a spike in U.S. demand for potassium iodide.

That includes products made at Fenton-based Fleming Pharmaceuticals.

They expect to run out of their supply of ThyroShield sometime this week, and they’re fractically trying to ramp up production.

ThyroShield is a liquid medicine that sells for about $13 per 45-millileter bottle, and is designed for use in “radiation emergencies”.

Meanwhile, health officials are stressing that Japan’s nuclear worries currently pose no threat to U.S. citizens in an effort to stop the run on the product here at home.

Copyright KMOX Radio

Comments (2)
  1. Lottie Russell says:

    Again this is a wonder showing of the world’s people helping beyond themselves.

Leave a Reply

Please log in using one of these methods to post your comment:

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

More From CBS St. Louis

Download The App

Listen Live